Researchers are hopeful an experimental drug called AT-1001 could be a new treatment for celiac disease, which now is managed only by a gluten-free diet. The drug works by inhibiting a protein that regulates the absorption of nutrients, essentially keeping gluten out of the small intestine. So far, patients who have taken the drug seem to be able to tolerate foods containing gluten with few or no side effects.

Related Summaries